India’s food safety regulator has initiated legal action against Nestlé after a follow-up formula milk product for infants was found to be substandard because its biotin content did not meet the prescribed Indian standard. The finding followed reanalysis of the sample, according to the Food Safety and Standards Authority of India (FSSAI), bringing renewed attention to how infant nutrition products are tested, labelled and monitored after they reach the market.
The regulator’s action concerns a baby-food product described as a follow-up formula. FSSAI said the product had inadequate levels of biotin, also known as vitamin B7, and that reanalysis confirmed the initial finding. The regulator has initiated adjudication proceedings, while separate cases have also been filed concerning allegedly misleading labelling on two other Nestlé products, NAN Excella Pro Stage 1 and Lactogen Pro 1.
Nestlé has disputed the regulatory concerns. The company said its products comply with applicable regulations and pointed to previous approval of the labels by an FSSAI expert committee. That difference between regulatory findings and the company’s position will now form part of the legal and regulatory process.
Why biotin matters in infant nutrition
Biotin is one of several B vitamins involved in the body’s metabolism and normal physiological functions. Infant formula products are manufactured with specified nutritional compositions because babies depend heavily on the nutritional adequacy of such products when breast milk is unavailable or when formula is medically or otherwise appropriately used.
That makes compliance with nutritional standards different from an ordinary food-quality dispute. The issue is not simply whether a product looks or tastes different from what a consumer expects. The prescribed composition itself is part of the safety and quality framework.
The FSSAI action therefore places the focus on a basic question in food regulation: whether products marketed for a particularly sensitive consumer group consistently meet the nutritional standards declared and required under Indian law.
What happens after a food regulator finds a product deficient?
A regulatory finding does not automatically mean that every unit of a product is unsafe, nor does it by itself establish that consumers have suffered harm. The immediate issue is whether the product complied with the applicable standard and what regulatory action follows from that finding.
In this case, FSSAI has initiated legal proceedings. The regulator has not indicated in the reported action that a recall has been ordered. That distinction matters because regulatory enforcement can involve several stages, including adjudication, directions to the company and further examination of products or manufacturing processes.
For parents, however, the episode highlights why product labels and regulatory compliance matter particularly when buying infant nutrition products.
The larger food-safety question
India’s packaged-food industry has expanded rapidly, creating a much larger task for regulators. Food safety is no longer limited to checking whether a product has been contaminated or whether a restaurant is maintaining hygiene standards. Nutritional composition, claims made on packaging and the accuracy of labels are also part of the regulatory system.
The Nestlé case also shows why independent testing and reanalysis are important. Companies may maintain that their products meet regulatory requirements, while regulators may arrive at a different finding from laboratory testing. A transparent process is necessary to establish the facts and determine the appropriate action.
The present case will now move through the regulatory process. FSSAI’s findings concern specific products and standards; they should not be treated as evidence that all Nestlé products are defective.
For consumers, particularly parents buying infant nutrition products, the immediate practical point is to follow official regulatory advisories and product-specific directions rather than relying on social-media claims or broad statements about a brand.
The legal proceedings will determine the consequences of the specific findings made by the food regulator.
